GE Healthcare
337
29
37
204
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
18.4%
62 terminated/withdrawn out of 337 trials
76.7%
-9.9% vs industry average
16%
53 trials in Phase 3/4
51%
104 of 204 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (337)
Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy
Role: collaborator
A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies
Role: lead
Maternal Fetal Device Performance Twins
Role: lead
Low-dose Contrast Media for Low-kVp Abdomen CT
Role: collaborator
Automated Non-Invasive Blood Pressure Study
Role: lead
Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.
Role: collaborator
Data Collection of New Spectral CT Imaging Method
Role: lead
Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
Role: collaborator
MCE Molecular Imaging for Myocarditis
Role: collaborator
Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study
Role: lead
3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis
Role: collaborator
Medical Imaging to Re-evaluate Elacestrant Clinical Usage
Role: collaborator
Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function
Role: collaborator
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Role: collaborator
Pars Healing on MRI
Role: collaborator
GSI Cardiac on Revolution Apex - US
Role: lead
NIBP Accuracy Study for Adult Subject Populations
Role: lead
NMT EasyFit Sensor and Cable
Role: lead
Non-Invasive Blood Pressure Accuracy Study for Adult Subject Populations
Role: lead
NIBP Accuracy Study for Adult
Role: lead